|
Sign In to gain access to subscriptions and/or personal tools.
|
Multi-state models for event history analysis
Per Kragh Andersen
Department of Biostatistics, University of Copenhagen, Denmark and Danish Epidemiology Science Centre, Copenhagen, Denmark, pka{at}biostat.ku.dk
Niels Keiding
Department of Biostatistics, University of Copenhagen, Denmark
An introduction to event history analysis via multi-state models is given. Examples include the two-state model for survival analysis, the competing risks and illness-death models, and models for bone marrow transplantation. Statistical model specification via transition intensities and likelihood inference is introduced. Consequences of observational patterns are discussed, and a real example concerning mortality and bleeding episodes in a liver cirrhosis trial is discussed.
Statistical Methods in Medical Research, Vol. 11, No. 2,
91-115 (2002)
DOI: 10.1191/0962280202SM276ra

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Chen, S. C. Shiboski, J. A. Golden, M. K. Gould, S. R. Hays, C. W. Hoopes, and T. De Marco
Impact of the Lung Allocation Score on Lung Transplantation for Pulmonary Arterial Hypertension
Am. J. Respir. Crit. Care Med.,
September 1, 2009;
180(5):
468 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vansteelandt, K. Mertens, C. Suetens, and E. Goetghebeur
Marginal structural models for partial exposure regimes
Biostat.,
January 1, 2009;
10(1):
46 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Beyersmann and M. Schumacher
Time-dependent covariates in the proportional subdistribution hazards model for competing risks
Biostat.,
October 1, 2008;
9(4):
765 - 776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Godeau, R. Porcher, O. Fain, F. Lefrere, P. Fenaux, S. Cheze, A. Vekhoff, M.-P. Chauveheid, J. Stirnemann, L. Galicier, et al.
Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study
Blood,
August 15, 2008;
112(4):
999 - 1004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kang and S. W. Lagakos
Statistical methods for panel data from a semi-Markov process, with application to HPV
Biostat.,
April 1, 2007;
8(2):
252 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A Gerds and M. Vogeler
Endpoints and survival analysis for successful osseointegration of dental implants
Statistical Methods in Medical Research,
December 1, 2005;
14(6):
579 - 590.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Welton and A. E. Ades
Estimation of Markov Chain Transition Probabilities and Rates from Fully and Partially Observed Data: Uncertainty Propagation, Evidence Synthesis, and Model Calibration
Med Decis Making,
November 1, 2005;
25(6):
633 - 645.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bonneterre, C. Bercez, M.-E. Bonneterre, X. Lenne, and B. Dervaux
Cost-effectiveness analysis of breast cancer adjuvant treatment: FEC 50 versus FEC 100 (FASG05 study)
Ann. Onc.,
June 1, 2005;
16(6):
915 - 922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Borgan
Estimation of covariate-dependent Markov transition probabilities from nested case-control data
Statistical Methods in Medical Research,
April 1, 2002;
11(2):
183 - 202.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. Andersen, S. Z Abildstrom, and S. Rosthoj
Competing risks as a multi-state model
Statistical Methods in Medical Research,
April 1, 2002;
11(2):
203 - 215.
[Abstract]
[PDF]
|
 |
|
|
|